Guangdong VTR Bio-Tech Co Ltd (SHE:300381) — Market Cap & Net Worth
Market Cap & Net Worth: Guangdong VTR Bio-Tech Co Ltd (300381)
Guangdong VTR Bio-Tech Co Ltd (SHE:300381) has a market capitalization of $411.74 Million (CN¥2.81 Billion) as of August 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #13070 globally and #3813 in its home market, demonstrating a 2.69% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Guangdong VTR Bio-Tech Co Ltd's stock price CN¥5.73 by its total outstanding shares 491061461 (491.06 Million). See 300381 capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
Guangdong VTR Bio-Tech Co Ltd Market Cap History: 2015 to 2026
Guangdong VTR Bio-Tech Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.26 Billion to $411.74 Million (-6.27% CAGR).
Guangdong VTR Bio-Tech Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Guangdong VTR Bio-Tech Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.56x
Guangdong VTR Bio-Tech Co Ltd's market cap is 0.56 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.62 Billion | $1.51 Billion | $113.57 Million | 1.07x | 14.26x |
| 2017 | $897.24 Million | $1.50 Billion | $80.42 Million | 0.60x | 11.16x |
| 2018 | $562.07 Million | $1.77 Billion | $113.51 Million | 0.32x | 4.95x |
| 2019 | $680.52 Million | $2.05 Billion | $127.52 Million | 0.33x | 5.34x |
| 2020 | $747.84 Million | $1.91 Billion | $161.71 Million | 0.39x | 4.62x |
| 2021 | $823.99 Million | $1.89 Billion | -$118.91 Million | 0.44x | N/A |
| 2022 | $534.69 Million | $1.17 Billion | $18.23 Million | 0.46x | 29.33x |
| 2023 | $524.57 Million | $796.02 Million | -$10.75 Million | 0.66x | N/A |
| 2024 | $504.44 Million | $826.20 Million | $31.09 Million | 0.61x | 16.22x |
| 2025 | $468.51 Million | $832.26 Million | -$19.78 Million | 0.56x | N/A |
Competitor Companies of 300381 by Market Capitalization
Companies near Guangdong VTR Bio-Tech Co Ltd in the global market cap rankings as of August 4, 2026.
Key companies related to Guangdong VTR Bio-Tech Co Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #424 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #543 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #563 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $477.10 |
| #424 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $762.63 |
| #543 | Argen-X | BR:ARGX | $49.55 Billion | €745.00 |
| #563 | UCB SA | BR:UCB | $47.34 Billion | €222.90 |
Guangdong VTR Bio-Tech Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Guangdong VTR Bio-Tech Co Ltd's market cap moved from $1.26 Billion to $ 411.74 Million, with a yearly change of -6.27%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥411.74 Million | -12.12% |
| 2025 | CN¥468.51 Million | -7.12% |
| 2024 | CN¥504.44 Million | -3.84% |
| 2023 | CN¥524.57 Million | -1.89% |
| 2022 | CN¥534.69 Million | -35.11% |
| 2021 | CN¥823.99 Million | +10.18% |
| 2020 | CN¥747.84 Million | +9.89% |
| 2019 | CN¥680.52 Million | +21.07% |
| 2018 | CN¥562.07 Million | -37.36% |
| 2017 | CN¥897.24 Million | -44.61% |
| 2016 | CN¥1.62 Billion | +28.57% |
| 2015 | CN¥1.26 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Guangdong VTR Bio-Tech Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $411.74 Million USD |
| MoneyControl | $411.74 Million USD |
| MarketWatch | $411.74 Million USD |
| marketcap.company | $411.74 Million USD |
| Reuters | $411.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Guangdong VTR Bio-Tech Co Ltd
Guangdong VTR Bio-Tech Co., Ltd. researches, develops, produces, sells, and services bio-enzyme preparations, biosynthetics, and nutrition and health products in China and internationally. The company offers animal nutrition and health, biofuel, detergent, food and beverage, brewing, starch sweetness, bakery, plant extracts, pulp and paper, and textile enzymes, as well as biotechnology solutions.… Read more